A paleontologist at the National Museums of Kenya is spearheading an effort to make 3-D reconstructions of the institution’s fossils available internationally.

These antiviral proteins are produced by the body as a natural defense against viral infections and synthetic interferons might help prevent or treat the beginning stages of SARS-CoV-2 infection.

Universities and healthcare facilities are planning to use spit tests to conduct large-scale screening.

Life sciences professors and other staff make contingency plans for more coronavirus-related disruptions in the coming school year.

Experts identify childcare, which tends to fall to women, as one likely cause for the relative decrease in women’s scientific productivity compared with men’s.

Growing ranks of researchers on the spectrum are overcoming barriers—from neurotypical bias to sensory sensitivities—to shape autism science.

Many colleges and universities across the US have lost millions of dollars in revenue due to COVID-19.

In record time, scientists have gone from harvesting antibodies against SARS-CoV-2 from survivors of coronavirus infections to testing the antibodies’ safety as a drug in humans.

These webs of chromatin and proteins, released by immune cells to control microbial infections, could serve as a therapeutic target in coronavirus infections.